FDA Adverse Event Malfunction Summary report: N

ARCHITECT I2000SR ANALYZER

MDR report key: 1182669 · Received October 3, 2008

Report

Report Number
1628664-2008-00228
Event Type
Malfunction
Date Received
October 3, 2008
Date of Event
September 8, 2008
Report Date
September 11, 2008
Manufacturer
ABBOTT MANUFACTURING, INC.
Product Code
JJE
PMA / PMN Number
K983212
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THIS IS AN INITIAL REPORT. AN INVESTIGATION IS IN PROCESS. A FINAL REPORT WILL BE SUBMITTED WHEN THE INVESTIGATION IS COMPLETE.

Additional Manufacturer Narrative · 1

TO INVESTIGATE THIS ISSUE, THE INVESTIGATION TEAM REVIEWED THE COMPLAINT TEXT, THE INSTRUMENT LOGS, THE INSTRUMENT HISTORY, AND ARCHITECT SYSTEM LABELING. THE INSTRUMENT LOGS DID NOT COVER THAT DATE OF OCCURRENCE AND COULD NOT BE UTILIZED TO DETERMINE THE CAUSE OF THE COMPLAINT ISSUE. THE REVIEW SHOWED THE ARCHITECT SYSTEM OPERATIONS MANUAL DOES ADDRESS COMPONENT REPLACEMENT PROCEDURES AND ERRATIC RESULTS INCLUDING PROBABLE CAUSES AND CORRECTIVE ACTIONS. ADDITIONALLY THE REVIEW OF THE INSTRUMENT HISTORY SHOWED FOUR ADDITIONAL COMPLAINTS HAVE BEEN RECEIVED INVOLVING ERRATIC RESULTS. SERVICE HISTORY REVIEWS INDICATED THE FIELD SERVICE REPRESENTATIVE VISITED THE CUSTOMER SITE AND RESOLVED ERRATIC RESULTS ISSUES BY REPLACING MULTIPLE COMPONENTS, INCLUDING THE SAMPLE PROBE AND REAGENT CARTRIDGE REPLACEMENT. THE INVESTIGATION TEAM WERE UNABLE TO IDENTIFY THE CAUSE OF THE ISSUE EXPERIENCED AT THE ACCOUNT FACILITY. AFTER THE REPLACEMENT OF THE SAMPLE PROBE, THE INSTRUMENT IS FUNCTIONING AS INTENDED. REFERENCE WHERE IN LABELING THE EVENT IS ADDRESSED: THE ARCHITECT SYSTEM OPERATIONS MANUAL JUNE, 2007): SECTION 7, OPERATIONAL PRECAUTIONS AND LIMITATIONS OF RESULT INTERPRETATION ASSAY RESULTS MUST BE USED WITH OTHER CLINICAL DATA, FOR EXAMPLE, SYMPTOMS, OTHER TEST RESULTS, PATIENT HISTORY, CLINICAL IMPRESSIONS, INFORMATION AVAILABLE FROM CLINICAL EVALUATION, AND OTHER DIAGNOSTIC PROCEDURES. ALL DATA MUST BE CONSIDERED FOR PATIENT CARE MANAGEMENT. IF ASSAY RESULTS ARE INCONSISTENT WITH CLINICAL EVIDENCE, ADDITIONAL TESTING IS SUGGESTED TO CONFIRM THE RESULT. THE ARCHITECT SYSTEM HAS BEEN VALIDATED FOR ITS INTENDED USE. HOWEVER, ERRORS CAN OCCUR DUE TO POTENTIAL OPERATOR ERRORS AND ARCHITECT SYSTEM TECHNOLOGY LIMITATIONS. SECTION 9: SERVICE AND MAINTENANCE: COMPONENT REPLACEMENT PROVIDES THOROUGH INSTRUCTIONS ON THE PROCEDURE TO REMOVE, REPLACE, AND VERIFY A SAMPLE PROBE. IN SECTION 10: TROUBLESHOOTING AND DIAGNOSTICS UNDER OBSERVED PROBLEMS LIST MULTIPLE PROBABLE CAUSES AND RESOLUTIONS RELATED TO THE CUSTOMER ISSUE. IN THE ARCHITECT TOTAL BETA-HUMAN CHORIONIC GONADOTROPIN REAGENT PACKAGE INSERT, LITERATURE IS PROVIDED IN DESCRIBING SUITABLE SPECIMENS, RESULTS, AND LIMITATIONS OF THE PROCEDURE. THIS IS A FINAL REPORT.

Description of Event or Problem · 1

THE CUSTOMER STATES THAT A PATIENT SAMPLE GENERATED AN ARCHITECT B-HCG RESULT OF 4 IU/L (SAMPLE 1). THE CUSTOMER HAS SET UP THE ANALYZER TO REFLEX TEST ALL THE B-HCG RESULTS BETWEEN 2 IU/L AND 35 IU/L WITH THE ROBOTIC SAMPLE HANDLER (RSH) SET TO AUTOMATICALLY REPOSITION SAMPLES FOR RERUNS. THE REPEAT RESULT FOR THE SAME PATIENT (SAMPLE 1) FOR B-HCG WAS 799 IU/L, WHICH WAS REPORTED AND QUESTIONED BY A PHYSICIAN. THE RETESTING WAS PERFORMED AT THE PHYSICIAN?S REQUEST AND A RESULT OF 3 IU/L WAS REPORTED TO THE PHYSICIAN. FURTHER INVESTIGATION FOUND THAT THE INITIAL SAMPLE (SAMPLE 1) WAS PLACED ONE POSITION DOWN FROM ANOTHER SAMPLE (SAMPLE 2) IN THE CARRIER AND THE CUSTOMER IS CONCERNED THAT THE ANALYZER MAY HAVE ASPIRATED FROM THE INCORRECT SAMPLE. THE OTHER SAMPLE (SAMPLE 2) RESULT WAS 834 IU/L. FURTHER TESTING VERIFIED THAT THE B-HCG RESULTS OF 4 IU/L (SAMPLE 1) AND 834 IU/L (SAMPLE 2) WERE CORRECT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ARCHITECT I2000SR ANALYZER AUTOMATED IMMUNOASSAY ANALYZER JJE ABBOTT MANUFACTURING, INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1 NI